Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$98.98 - $115.74 $197 - $231
-2 Reduced 0.12%
1,671 $193,000
Q2 2023

Jul 28, 2023

SELL
$96.34 - $112.38 $2,601 - $3,034
-27 Reduced 1.59%
1,673 $172,000
Q1 2023

Apr 26, 2023

SELL
$107.32 - $113.5 $548,727 - $580,325
-5,113 Reduced 75.05%
1,700 $185,000
Q4 2022

Jan 24, 2023

BUY
$62.39 - $113.8 $4,367 - $7,966
70 Added 1.04%
6,813 $0
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $3,417 - $4,910
-58 Reduced 0.85%
6,743 $417,000
Q2 2022

Aug 01, 2022

BUY
$79.4 - $116.36 $635 - $930
8 Added 0.12%
6,801 $542,000
Q1 2022

Apr 21, 2022

SELL
$86.42 - $109.81 $518 - $658
-6 Reduced 0.09%
6,793 $715,000
Q4 2021

Jan 18, 2022

BUY
$98.56 - $119.91 $572,732 - $696,797
5,811 Added 588.16%
6,799 $733,000
Q3 2021

Nov 05, 2021

BUY
$91.91 - $110.37 $20,771 - $24,943
226 Added 29.66%
988 $108,000
Q2 2021

Jul 27, 2021

SELL
$86.24 - $95.92 $17,248 - $19,184
-200 Reduced 20.79%
762 $71,000
Q1 2021

Apr 28, 2021

SELL
$71.83 - $95.48 $39,793 - $52,895
-554 Reduced 36.54%
962 $89,000
Q4 2020

Jan 27, 2021

BUY
$67.0 - $84.39 $35,912 - $45,233
536 Added 54.69%
1,516 $111,000
Q3 2020

Nov 03, 2020

BUY
$55.23 - $79.93 $44,625 - $64,583
808 Added 469.77%
980 $76,000
Q2 2020

Jul 27, 2020

SELL
$30.2 - $56.98 $1,026 - $1,937
-34 Reduced 16.5%
172 $10,000
Q1 2020

Apr 22, 2020

SELL
$24.87 - $38.56 $19,746 - $30,616
-794 Reduced 79.4%
206 $6,000
Q2 2019

Jul 24, 2019

BUY
$22.81 - $28.48 $22,810 - $28,480
1,000 New
1,000 $24,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.